• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level. A further analysis. Hypertension Detection and Follow-up Program Cooperative Group.

出版信息

J Community Health. 1984 Summer;9(4):314-27.

PMID:6480895
Abstract

The Hypertension Detection and Follow-up Program (HDFP) data are reported by diastolic blood pressure (DBP) stratum for four race-sex subgroups. For Stratum I (entry DBP 90-104 mm Hg) in each of the race-sex subgroups (black male, black female, white male, and white female). Stepped Care (SC) participants experienced a reduced mortality as compared to Referred Care (RC). For black males and females in all three entry DBP strata, mortality was lower in the SC than RC. Only in three subgroups did the SC mortality exceed RC: Stratum II (entry DBP 105-114 mm Hg) white females and Stratum III (entry DBP 115 + mm Hg) white males and females. Possible explanations for these deviant findings are discussed. The HDFP was designed to determine the difference in total 5-year mortality between SC and RC; subgroup analyses may be subject to large chance variation and must be interpreted with great caution. The value of vigorous treatment of "mild" hypertension (Stratum I) in males and females, black and white, and the value of treatment for all blood pressure strata in blacks are confirmed by this analysis.

摘要

相似文献

1
Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level. A further analysis. Hypertension Detection and Follow-up Program Cooperative Group.
J Community Health. 1984 Summer;9(4):314-27.
2
Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group.
JAMA. 1979 Dec 7;242(23):2572-7. doi: 10.1001/jama.1979.03300230028022.
3
Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.高血压检测与随访项目的五年研究结果。一、高血压患者(包括轻度高血压患者)死亡率的降低。高血压检测与随访项目协作组
JAMA. 1979 Dec 7;242(23):2562-71.
4
Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group.
JAMA. 1988 Apr 8;259(14):2113-22.
5
Mortality findings beyond five years in the hypertension detection and follow-up program (HDFP).
J Hypertens Suppl. 1988 Dec;6(4):S597-601. doi: 10.1097/00004872-198812040-00187.
6
Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group.高血压检测与随访项目的五年研究结果。III. 高血压患者中风发病率的降低。高血压检测与随访项目合作组
JAMA. 1982 Feb 5;247(5):633-8.
7
Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. The Hypertension Detection and Follow-up Program Cooperative Research Group.
Prev Med. 1985 May;14(3):312-35. doi: 10.1016/0091-7435(85)90059-3.
8
Blood pressure studies in 14 communities. A two-stage screen for hypertension.14个社区的血压研究。高血压的两阶段筛查。
JAMA. 1977 May 30;237(22):2385-91. doi: 10.1001/jama.1977.03270490025018.
9
Status of patients seven years after completion of the hypertension detection and follow-up program in Evans County, Georgia.佐治亚州埃文斯县高血压检测与随访项目结束七年后患者的状况。
J Natl Med Assoc. 1988 Dec;80(12):1285-92.
10
Systolic blood pressure as an independent predictor of mortality in the Hypertension Detection and Follow-up Program.
Am J Prev Med. 1986 May-Jun;2(3):123-32.

引用本文的文献

1
Reducing racial and ethnic disparities in hypertension prevention and control: what will it take to translate research into practice and policy?减少高血压预防与控制方面的种族和族裔差异:将研究转化为实践和政策需要付出什么?
Am J Hypertens. 2015 Jun;28(6):699-716. doi: 10.1093/ajh/hpu233. Epub 2014 Dec 12.
2
Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review.抗高血压治疗预防心血管结局试验中的种族和族裔:一项系统评价
Ann Fam Med. 2007 Sep-Oct;5(5):444-52. doi: 10.1370/afm.708.
3
Managing hypertension with combination diuretics and methyldopa in nigerian blacks at the primary care level.

本文引用的文献

1
Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease.
Circulation. 1980 Mar;61(3):508-15. doi: 10.1161/01.cir.61.3.508.
2
Management of the hypertensive patient: a continuing dilemma.高血压患者的管理:一个持续存在的难题。
Hypertension. 1981 Mar-Apr;3(2):192-7. doi: 10.1161/01.hyp.3.2.192.
3
The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program.治疗对“轻度”高血压患者死亡率的影响:高血压检测与随访项目的结果
在初级保健水平上用联合利尿剂和甲基多巴治疗尼日利亚黑人的高血压。
Clin Drug Investig. 2003;23(9):583-90. doi: 10.2165/00044011-200323090-00004.
4
On reconsidering community-based health promotion.重新审视基于社区的健康促进
Am J Public Health. 2003 Aug;93(8):1201; author reply 1201-2. doi: 10.2105/ajph.93.8.1201.
5
Optimal treatment of hypertension and cardiovascular risk reduction in African Americans: treatment approaches for outpatients.非裔美国人高血压的最佳治疗与心血管风险降低:门诊治疗方法
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1 Suppl 1):18-25. doi: 10.1111/j.1524-6175.2003.02180.x.
6
Epidemiology of hypertension and cardiovascular disease in African Americans.非裔美国人高血压和心血管疾病的流行病学
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1 Suppl 1):5-11. doi: 10.1111/j.1524-6175.2003.02152.x.
7
Introduction: management of hypertension and cardiovascular risk factors in African Americans.引言:非裔美国人高血压及心血管危险因素的管理
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1 Suppl 1):3-4. doi: 10.1111/j.1524-6175.2003.02016.x.
8
The association between hypertension and other cardiovascular risk factors in young adult African Americans.年轻成年非裔美国人中高血压与其他心血管危险因素之间的关联。
J Clin Hypertens (Greenwich). 2002 Jan-Feb;4(1):17-22. doi: 10.1111/j.1524-6175.2002.01211.x.
9
Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.替米沙坦与氢氯噻嗪联合治疗黑人轻至中度高血压患者。
Clin Cardiol. 2001 Jan;24(1):66-72. doi: 10.1002/clc.4960240111.
10
How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure.如何在高血压治疗中使用钙拮抗剂:将美国国家高血压教育计划第六次报告(JNC-VI)指南付诸实践。国家高血压预防、检测、评估与治疗联合委员会
Drugs. 1999 Oct;58(4):579-87. doi: 10.2165/00003495-199958040-00001.
N Engl J Med. 1982 Oct 14;307(16):976-80. doi: 10.1056/NEJM198210143071603.
4
Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.多重危险因素干预试验。危险因素变化及死亡率结果。多重危险因素干预试验研究组。
JAMA. 1982 Sep 24;248(12):1465-77.
5
Mild hypertension: new light on an old clinical controversy.轻度高血压:旧有临床争议的新见解
Am J Med. 1980 Nov;69(5):653-5. doi: 10.1016/0002-9343(80)90413-1.
6
Whom to treat: the dilemma of mild hypertension.治疗对象:轻度高血压的困境。
Am Heart J. 1981 Jun;101(6):867-70. doi: 10.1016/0002-8703(81)90636-0.
7
The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group.
Prev Med. 1976 Jun;5(2):207-15. doi: 10.1016/0091-7435(76)90039-6.
8
Race, education and prevalence of hypertension.
Am J Epidemiol. 1977 Nov;106(5):351-61.
9
Blood pressure studies in 14 communities. A two-stage screen for hypertension.14个社区的血压研究。高血压的两阶段筛查。
JAMA. 1977 May 30;237(22):2385-91. doi: 10.1001/jama.1977.03270490025018.
10
The hypertension detection and follow-up program: a progress report.高血压检测与随访项目:进展报告。
Circ Res. 1977 May;40(5 Suppl 1):I106-9.